DiaSorin DiaSorin Q3 Revenues Rise 51 Percent on Luminex Acquisition, Recovery of Non-COVID Test Sales DiaSorin said in Q3 it saw a strong recovery of non-COVID test sales including for latent tuberculosis and other infectious diseases as well as gastrointestinal infections. DiaSorin Molecular Receives CE Mark for Multiplex COVID-19, Influenza Test The test detects and differentiates between nucleic acids from SARS-CoV-2 and influenza A/B from the same sample in one reaction well. DiaSorin Q2 Revenues Rise 20 Percent on SARS-CoV-2 Testing Demand DiaSorin posted Q2 molecular revenues of €69.4 million, up 23 percent year over year from €56.6 million. DiaSorin Q1 Revenues Rise 53 Percent on SARS-CoV-2 Testing Demand The company said that its Q1 revenue growth was driven in part by SARS-CoV-2 test revenues of €102.0 million, booked mainly in the US, Canada, and Europe. With Luminex Acquisition, DiaSorin to Broaden MDx Portfolio, Expand US Presence Premium DiaSorin said that the acquisition gives it access to Luminex's multiplexing technology, tests, and instruments and strengthens its MDx product portfolio. Apr 12, 2021 DiaSorin to Acquire Luminex for $1.8B Feb 25, 2021 Luminex Shares Surge on Rumor of Acquisition by DiaSorin Jan 13, 2021 BARDA Provides Additional Funding to DiaSorin Molecular for COVID-19 Tests Sep 17, 2020 DiaSorin Receives CE Mark to Use Saliva Samples With COVID-19 Test Sep 8, 2020 FDA Clears DiaSorin Test for Influenza, RSV Jul 7, 2020 DiaSorin Molecular Gets CE Mark for Flu, RSV Assay Jun 15, 2020 DiaSorin Molecular Gets CE Mark for Congenital CMV Assay Apr 13, 2020 Coronavirus Tests From Seegene, DiaSorin, Others Get Health Canada Approval Mar 20, 2020 Coronavirus Test From DiaSorin Molecular Gets FDA Emergency Use Authorization Mar 13, 2020 DiaSorin Molecular Awarded $679K BARDA Funding to Develop Coronavirus Test Mar 2, 2020 TTP Licenses Sample-to-Answer Dx System to DiaSorin Dec 17, 2019 FDA Clears DiaSorin Molecular VZV Test Sep 25, 2019 DiaSorin Molecular Gets CE Mark for VZV Swab Direct Molecular Test May 30, 2019 FDA Clears DiaSorin Molecular Meningitis, Encephalitis Assay May 16, 2019 DiaSorin Molecular Gets CE Mark for Herpes Virus Assay Jan 8, 2019 DiaSorin Whooping Cough Test Clears FDA With Additional Claim Nov 26, 2018 Group B Strep Test From DiaSorin Molecular Cleared by FDA Oct 18, 2018 DiaSorin Receives CE Mark for Simplexa Group B Strep Assay Breaking News Flatiron Health, Japanese Hospital Partner on Real-World GI Cancer Database Abbott Q4 Diagnostics Revenues Grow 3 Percent, Full-Year Revenues up 25 Percent Molecular Diagnostics Firm Mainz Biomed Prices $22.5M Follow-on Share Offering Dante Labs to Refund COVID-19 Test Customers Following UK Regulatory Investigation Lifespan Linked to Lower Protein Synthesis Gene Expression Pathogenic Variants in Disease-Causing Genes Have Low Penetrance on Average, Study Finds The Scan Sensor to Spot SARS-CoV-2 Exposure Yale researchers have developed a sensor that gauges SARS-CoV-2 exposure, according to the New Haven Register. Watching BA.2 A subtype of the Omicron SARS-CoV-2 variant has been found in a number of countries, the Washington Post says. Vermont Weighs Genetic Discrimination Bill VT Digger reports Vermont legislators are considering a bill to bar insurer from denying customers coverage based on genetic information. PNAS Papers on Convergent Pathogen Effectors, Lineage-Related RNA Mutations, Desiccation-Tolerant Grass In PNAS this week: convergent evolution of pathogen effectors, algorithm to identify cell lineage features, and more.